A. Vogt

发表

Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).

R. Bartenschlager, T. Sauerbruch, W. Caselmann, 2013, Antiviral research.

Immune Check Point CD40–CD40L Activates Dendritic and Effector Cells Against Human Renal Carcinoma Cells

C. Strassburg, M. Gonzalez-Carmona, A. Vogt, 2019, AntiCancer Research.

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

C. Strassburg, J. Nattermann, H. Matthaei, 2022 .

Induction of cytotoxic effector cells towards cholangiocellular, pancreatic, and colorectal tumor cells by activation of the immune checkpoint CD40/CD40L on dendritic cells

C. Strassburg, H. Matthaei, M. Gonzalez-Carmona, 2020, Cancer Immunology, Immunotherapy.

Inhibition of hepatitis C virus gene expression by adenoviral vectors encoding antisense RNA in vitro and in vivo.

R. Bartenschlager, T. Sauerbruch, W. Caselmann, 2011, Journal of hepatology.

Alpha-Fetoprotein- and CD40Ligand-Expressing Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma

C. Strassburg, H. Matthaei, M. Gonzalez-Carmona, 2021, Cancers.

siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.

T. Sauerbruch, V. Schmitz, A. Vogt, 2008, Journal of hepatology.

CD40ligand‐expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo

T. Sauerbruch, V. Schmitz, W. Caselmann, 2008, Hepatology.

No functional and transductional significance of specific neuropilin 1 siRNA inhibition in colon carcinoma cell lines lacking VEGF receptor 2.

T. Sauerbruch, V. Schmitz, M. Quante, 2009, Oncology reports.

Plasminogen fragment K1–5 improves survival in a murine hepatocellular carcinoma model

T. Sauerbruch, V. Schmitz, W. Caselmann, 2006, Gut.

Regulation of NK cell trafficking by CD81

J. Nattermann, H. Nischalke, T. Sauerbruch, 2009, European journal of immunology.

Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma

C. Strassburg, J. Nattermann, H. Matthaei, 2019, Alimentary pharmacology & therapeutics.

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors

I. Schmidt-Wolf, M. Gonzalez-Carmona, A. Vogt, 2014, Journal of immunology research.

Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL‐12 in vivo

C. Strassburg, T. Sauerbruch, H. Büning, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Programmed cell death protein 1 (PD-1)-inhibition in hepatocellular carcinoma (HCC): a single center experience

C. Strassburg, H. Matthaei, M. Essler, 2020, Scandinavian journal of gastroenterology.

Angiotensin‐II type 1 receptor‐mediated Janus kinase 2 activation induces liver fibrosis

J. Nattermann, T. Sauerbruch, V. Shah, 2014, Hepatology.

Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells.

F. Lammert, M. Odenthal, T. Sauerbruch, 2010, Journal of hepatology.

Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma

C. Strassburg, J. Nattermann, H. Nischalke, 2019, Cancer Immunology, Immunotherapy.

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

C. Strassburg, J. Nattermann, H. Matthaei, 2022, Scientific Reports.

Beta‐glucosidase 2 knockout mice with increased glucosylceramide show impaired liver regeneration

F. Tacke, F. Lammert, A. Canbay, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Inhibition of Neuropilin-1 by RNA-Interference and its Angiostatic Potential in the Treatment of Hepatocellular Carcinoma

T. Sauerbruch, V. Schmitz, J. Standop, 2010, Zeitschrift fur Gastroenterologie.

Plasminogen fragment K1–3 inhibits expression of adhesion molecules and experimental HCC recurrence in the liver

T. Sauerbruch, V. Schmitz, J. Standop, 2009, International Journal of Colorectal Disease.

Plasminogen Derivatives Encoding Kringles 1-4 and Kringles 1-5 Exert Indirect Antiangiogenic and Direct Antitumoral Effects in Experimental Lung Cancer

T. Sauerbruch, V. Schmitz, W. Caselmann, 2008, Cancer investigation.

Adeno‐associated virus serotype 2 capsid variants for improved liver‐directed gene therapy

Q. Yuan, M. Ott, M. Odenthal, 2022, Hepatology.

siRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo.

T. Sauerbruch, V. Schmitz, A. Vogt, 2008, Journal of hepatology.

Regulatory T Cell Inhibition by P60 Combined with Adenoviral AFP Transduced Dendritic Cells for Immunotherapy of Hepatocellular Carcinoma.

H. Matthaei, J. Lasarte, P. Sarobe, 2023, Immunological investigations.

Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapy

C. Strassburg, J. Nattermann, H. Matthaei, 2022, Scientific Reports.

Regulation of NK cell trafficking by CD81

J. Nattermann, H. Nischalke, T. Sauerbruch, 2009, European journal of immunology.

FOXP3 Inhibitory Peptide P60 Increases Efficacy of Cytokine-induced Killer Cells Against Renal and Pancreatic Cancer Cells

C. Strassburg, J. Lasarte, M. Gonzalez-Carmona, 2019, AntiCancer Research.